Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability

Lately, long noncoding (lnc) RNAs are increasingly appreciated for their involvement in multiple sclerosis (MS). In inflammation and autoimmunity, a role of apoprotein A1 (ApoA1), mediated by sphingosine 1-phosphate receptors (S1PRs), was reported. However, the epigenetic mechanisms regulating these...

Full description

Bibliographic Details
Main Authors: Heba R. Ghaiad, Alaa N. Elmazny, Mohammed M. Nooh, Maha M. El-Sawalhi, Amira A. Shaheen
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Journal of Advanced Research
Online Access:http://www.sciencedirect.com/science/article/pii/S209012321930178X
_version_ 1828866047329959936
author Heba R. Ghaiad
Alaa N. Elmazny
Mohammed M. Nooh
Maha M. El-Sawalhi
Amira A. Shaheen
author_facet Heba R. Ghaiad
Alaa N. Elmazny
Mohammed M. Nooh
Maha M. El-Sawalhi
Amira A. Shaheen
author_sort Heba R. Ghaiad
collection DOAJ
description Lately, long noncoding (lnc) RNAs are increasingly appreciated for their involvement in multiple sclerosis (MS). In inflammation and autoimmunity, a role of apoprotein A1 (ApoA1), mediated by sphingosine 1-phosphate receptors (S1PRs), was reported. However, the epigenetic mechanisms regulating these biomolecules and their role in MS remains elusive. This case control study investigated the role of ApoA1, sphingosine kinase 1 and 2 (SPHK1 & 2), S1PR1 & 5, interferon-γ (IFN-γ) and interleukin 17 (IL17) in MS, beside three lncRNA: APOA1-AS, IFNG-AS1, and RMRP. Expression of SPHKs, S1PRs, and lncRNAs were measured in 72 relapsing-remitting MS patients (37 during relapse and 35 in remission) and 28 controls. Plasma levels of ApoA1, IFN-γ and IL17 were determined. The impact of these parameters on MS activity, relapse rate and patient disability was assessed. APOA1-AS, IFNG-AS1, SPHK1 & 2, and S1PR5 were upregulated in RRMS patients. Differences in ApoA1, SPHK2, and IL17 were observed between relapse and remission. Importantly, ApoA1, SPHK2, and IL17 were related to activity, while S1PR1 and IFN-γ were linked to disability, though, only IFN-γ was associated with relapse rate. Finally, an excellent diagnostic power of IFN-γ, IL17, SPHK1 and APOA1-AS was demonstrated, whereas SPHK2 showed promising prognostic power in predicting relapses. Keywords: Multiple sclerosis, LncRNA, Apoprotein A1, Interferon-γ, Sphingosine 1-phosphate receptors
first_indexed 2024-12-13T04:42:03Z
format Article
id doaj.art-a0f9b82abefb40aea301d136248686f1
institution Directory Open Access Journal
issn 2090-1232
language English
last_indexed 2024-12-13T04:42:03Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series Journal of Advanced Research
spelling doaj.art-a0f9b82abefb40aea301d136248686f12022-12-21T23:59:18ZengElsevierJournal of Advanced Research2090-12322020-01-0121141150Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disabilityHeba R. Ghaiad0Alaa N. Elmazny1Mohammed M. Nooh2Maha M. El-Sawalhi3Amira A. Shaheen4Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Corresponding author at: Biochemistry Department, Faculty of Pharmacy, Cairo University, Kasr el Ainy st., 11562 Cairo, Egypt.Neurology Department, Faculty of Medicine, Cairo University, Cairo, EgyptBiochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, EgyptBiochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, EgyptBiochemistry Department, Faculty of Pharmacy, Cairo University, Cairo, EgyptLately, long noncoding (lnc) RNAs are increasingly appreciated for their involvement in multiple sclerosis (MS). In inflammation and autoimmunity, a role of apoprotein A1 (ApoA1), mediated by sphingosine 1-phosphate receptors (S1PRs), was reported. However, the epigenetic mechanisms regulating these biomolecules and their role in MS remains elusive. This case control study investigated the role of ApoA1, sphingosine kinase 1 and 2 (SPHK1 & 2), S1PR1 & 5, interferon-γ (IFN-γ) and interleukin 17 (IL17) in MS, beside three lncRNA: APOA1-AS, IFNG-AS1, and RMRP. Expression of SPHKs, S1PRs, and lncRNAs were measured in 72 relapsing-remitting MS patients (37 during relapse and 35 in remission) and 28 controls. Plasma levels of ApoA1, IFN-γ and IL17 were determined. The impact of these parameters on MS activity, relapse rate and patient disability was assessed. APOA1-AS, IFNG-AS1, SPHK1 & 2, and S1PR5 were upregulated in RRMS patients. Differences in ApoA1, SPHK2, and IL17 were observed between relapse and remission. Importantly, ApoA1, SPHK2, and IL17 were related to activity, while S1PR1 and IFN-γ were linked to disability, though, only IFN-γ was associated with relapse rate. Finally, an excellent diagnostic power of IFN-γ, IL17, SPHK1 and APOA1-AS was demonstrated, whereas SPHK2 showed promising prognostic power in predicting relapses. Keywords: Multiple sclerosis, LncRNA, Apoprotein A1, Interferon-γ, Sphingosine 1-phosphate receptorshttp://www.sciencedirect.com/science/article/pii/S209012321930178X
spellingShingle Heba R. Ghaiad
Alaa N. Elmazny
Mohammed M. Nooh
Maha M. El-Sawalhi
Amira A. Shaheen
Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability
Journal of Advanced Research
title Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability
title_full Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability
title_fullStr Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability
title_full_unstemmed Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability
title_short Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: Relation to disease activity and patient disability
title_sort long noncoding rnas apoa1 as ifng as1 rmrp and their related biomolecules in egyptian patients with relapsing remitting multiple sclerosis relation to disease activity and patient disability
url http://www.sciencedirect.com/science/article/pii/S209012321930178X
work_keys_str_mv AT hebarghaiad longnoncodingrnasapoa1asifngas1rmrpandtheirrelatedbiomoleculesinegyptianpatientswithrelapsingremittingmultiplesclerosisrelationtodiseaseactivityandpatientdisability
AT alaanelmazny longnoncodingrnasapoa1asifngas1rmrpandtheirrelatedbiomoleculesinegyptianpatientswithrelapsingremittingmultiplesclerosisrelationtodiseaseactivityandpatientdisability
AT mohammedmnooh longnoncodingrnasapoa1asifngas1rmrpandtheirrelatedbiomoleculesinegyptianpatientswithrelapsingremittingmultiplesclerosisrelationtodiseaseactivityandpatientdisability
AT mahamelsawalhi longnoncodingrnasapoa1asifngas1rmrpandtheirrelatedbiomoleculesinegyptianpatientswithrelapsingremittingmultiplesclerosisrelationtodiseaseactivityandpatientdisability
AT amiraashaheen longnoncodingrnasapoa1asifngas1rmrpandtheirrelatedbiomoleculesinegyptianpatientswithrelapsingremittingmultiplesclerosisrelationtodiseaseactivityandpatientdisability